Dan Polen - Polen Capital Management
Holding/activity history for Ascendis Pharma A/S (ASND)
← All ASND superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,812 | <0.01 | Add 49.63% | <0.01 | $188.08–248.60 · VW $225.21i | $414,459 | SEC |
| 2025 Q4 | 1,211 | <0.01 | Reduce 56.22% | <0.01 | $186.05–229.94 · VW $207.81i | $258,234 | SEC |
| 2025 Q3 | 2,766 | <0.01 | Add 1.73% | $160.86–208.16 · VW $185.59i | $549,908 | SEC | |
| 2025 Q2 | 2,719 | <0.01 | Buy | <0.01 | $124.06–183.00 · VW $163.69i | $469,299 | SEC |
Price snapshot:
Current price$265.22
Avg. buy price$191.51
+/- since buy38.49%
52-week low$160.86
52-week high$282.15